Publication of an Article in Molecular Therapy Demonstrates That SB623 ImprovesCortical Excitability in Rats with Focal Cerebral Ischemia

The Yield Results of the Second Commercial Production Run for AKUUGO🄬 Suspension for Intracranial Implantation

The Results of the First Commercial Production Run to Meet the Approval Conditions for the Shipment of AKUUGO🄬 Suspension for Intracranial Implantation

On April 7, NeurologyLive published an interview with Dr. Peter McAllister regarding the final analysis of the Phase 2 STEMTRA trial.

Dr. Damien Bates, Chief Medical Officer and Head of Research at SanBio, publishes report in the leading medical journal, Stroke

Sawaguchi, Head of Japan Regulatory Affairs & Quality Compliance Japan, will speak at 【Regenerative Medicine Seminar 2024】“Development of Regenerative Medicine Products: Recent Trends in Regenerative Medicine and Other Related Issues” (Vol.5: Quality in Regenerative Medicine Products)” hosted by the Clinical and Translational Research Center (CTR) Keio University Hospital

MORI, President & CEO, will be a panelist at “Navigating Biopharma Innovation Across the Pacific” hosted by the U.S. Embassy and the Japan Society of Northern California on November 11

Presentation of Phase 2 STEMTRA Trial Results at The 14th World Congress on Brain Injury